Med devices, drugs, FDA regulation

The original intention of FDA “special status” programs such as “orphan status” and “breakthrough therapy” was to level the playing field by providing financial and development incentives to get drug...

Drug development companies often issue press releases touting that their drug has received special designations from the FDA citing terms such as “orphan” drug status, “fast track” approval and “breakthrough...